Literature DB >> 3154705

Calcium channel antagonists. Part V: Second-generation agents.

L H Opie1.   

Abstract

Second-generation agents include new dihydropyridines, such as amlodipine, felodipine, isradipine, nicardipine, nimodipine, nisoldipine, and nitrendipine. Verapamil-like agents include tiapamil, gallopamil, and anipamil. Among the diphenylalkylamines, bepridil is of special interest. New preparations of existing agents include slow-release formulations of nifedipine, verapamil, and diltiazem. From all these agents will be selected those that are longer-acting and provide higher vascular selectivity.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3154705     DOI： 10.1007/bf00051234

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN： 0920-3206            Impact factor:   3.727


  104 in total

1.  Effects of felodipine on pacing-induced angina pectoris.

Authors:  H Emanuelsson; A Hjalmarson; S Holmberg; F Waagstein
Journal:  J Cardiovasc Pharmacol       Date:  1986 May-Jun       Impact factor: 3.105

2.  Comparative acute effects of the calcium channel blockers tiapamil, nisoldipine, and nifedipine on blood pressure and some regulatory factors in normal and hypertensive subjects.

Authors:  K Laederach; P Weidmann; F Lauener; A Gerber; W H Ziegler
Journal:  J Cardiovasc Pharmacol       Date:  1986 Mar-Apr       Impact factor: 3.105

3.  Central hemodynamic changes of calcium antagonists at rest and during exercise in essential hypertension.

Authors:  P Lund-Johansen; P Omvik
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

4.  A double-blind crossover comparison of amlodipine and placebo added to captopril in moderate to severe hypertension.

Authors:  D Maclean; E T Mitchell; R G Wilcox; P Walker; H M Tyler
Journal:  J Cardiovasc Pharmacol       Date:  1988       Impact factor: 3.105

5.  Myocardial protection by intracoronary nicardipine administration during percutaneous transluminal coronary angioplasty.

Authors:  C Hanet; M F Rousseau; M F Vincent; E Lavenne-Pardonge; H Pouleur
Journal:  Am J Cardiol       Date:  1987-05-01       Impact factor: 2.778

6.  Prolongation of verapamil elimination kinetics during chronic oral administration.

Authors:  J B Schwartz; D L Keefe; E Kirsten; R E Kates; D C Harrison
Journal:  Am Heart J       Date:  1982-08       Impact factor: 4.749

7.  Nisoldipine: a new, more selective calcium current blocker in cardiac Purkinje fibers.

Authors:  R S Kass
Journal:  J Pharmacol Exp Ther       Date:  1982-11       Impact factor: 4.030

8.  Nisoldipine tablets once daily versus nifedipine capsules three times daily in patients with stable effort angina pectoris pretreated with atenolol.

Authors:  T R Pedersen; M Kantor
Journal:  Cardiovasc Drugs Ther       Date:  1990-04       Impact factor: 3.727

9.  Dose related coronary and systemic haemodynamic effects of intravenous bepridil in patients with coronary artery disease.

Authors:  W J Remme; D C van Hoogenhuyze; X H Krauss; A Hofman; C J Storm; H A Kruyssen
Journal:  Eur Heart J       Date:  1987-02       Impact factor: 29.983

10.  Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage.

Authors:  G S Allen; H S Ahn; T J Preziosi; R Battye; S C Boone; S C Boone; S N Chou; D L Kelly; B K Weir; R A Crabbe; P J Lavik; S B Rosenbloom; F C Dorsey; C R Ingram; D E Mellits; L A Bertsch; D P Boisvert; M B Hundley; R K Johnson; J A Strom; C R Transou
Journal:  N Engl J Med       Date:  1983-03-17       Impact factor: 91.245
View more
  1 in total

1.  Effects of the novel calcium channel blocker, anipamil, on the isolated rabbit heart. Comparison with verapamil and gallopamil.

Authors:  R Raddino; E Poli; E Pasini; R Ferrari
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.